Newsletter Signup x
RS Components (RS), a global multi-channel provider of industrial and electronic products and solutions, embarked on an epic charity cycle ride, covering 1,100 miles from Aberdeen to London on the 10 June 2019 with the ambitious goal of raising £250,000 for Children with Cancer UK.
The Tour de Branch was a physically challenging fundraiser, and had more than 60 employees from RS Components taking part. The 12 day course called at each of the 16 RS Components local branches nationwide, and averaged a daily mileage of around 90 miles and a climb to an altitude of 5,700 metres through Scotland in the first week. Just four strenuous cyclists took on the entire route, which finished at the company’s headquarters in Pancras Square on the 19 June 2019.
RS Components have been supporting Children with Cancer UK since 2017 as its chosen national charity, with employees taking part in activities such as marathons, mountain climbing, swimming, cycling, baking and dancing, with The Tour de Branch being their biggest challenge yet!
Now, a year after the challenge, the RS Components team have not only hit their target raising £250,000 – they have also unveiled a fantastic documentary that followed this unique fundraiser from start to finish.
Click play below to get a front row seat to the action.
Watch this short film documenting the biggest charity event in RS Components history. The planning started in September 2018 when their project team was being assembled and the documentary follows through the months of hard training, preparation and then into the ride itself.
Identification of new genetic changes in rhabdomyosarcoma
Rhabdomyosarcoma (RMS) is a childhood cancer that develops in muscle, with 50 new cases every year in the UK.
Read more
The Mia Pyari Fund
Total raised so far: £1,365
Mia Pyari was diagnosed with acute lymphoblastic leukaemia,
Read more
Investigate the clinical relevance of the remaining 15 subtypes and establish whether they can be used prospectively to guide treatment
The outcome for children and young people diagnosed with acute lymphoblastic leukaemia (CYP-ALL) has improved dramatically over the past
Read more